CTSO
CytoSorbents Corporation
Company Overview
| Mkt Cap | $52.48M | Price | $0.79 |
| Volume | 39.73K | Change | +1.65% |
| P/E Ratio | -2.5 | Open | $0.78 |
| Revenue | $35.6M | Prev Close | $0.78 |
| Net Income | $-20.7M | 52W Range | $0.71 - $1.61 |
| Div Yield | N/A | Target | $5.38 |
| Overall | 36 | Value | 40 |
| Quality | 50 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyCytoSorbents Corporation (CTSO) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $0.79 with a market capitalization of $52.48 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating average quality indicators with a MarketXLS quality score of 50.
Today's trading session shows CTSO with a volume of 40K shares. The stock opened down 0.08% from yesterday's close of $0.78. Current analyst estimates project earnings of $-0.16 per share for this year, with next year targeting $-0.16.
CTSO demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including VIVO, HOLX, NEPH, BSX, DXR.
Key investment considerations for CTSO include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 578.0%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 4, 2025 at 09:38 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTSO | $0.79 | +1.7% | 39.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CytoSorbents Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW